---
$id: https://graph.org.ai/products/commodity/51442705
$type: Product
source: UNSPSC
code: "51442705"
title: "Technetium Tc-99m fanolesomab or technetium 99mtc fanolesomab"
class: "51442700"
classTitle: "Technetium-based radiopharmaceuticals, imaging agents, media, and tracers"
family: "51440000"
familyTitle: "Radiopharmaceuticals and contrast media"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Technetium Tc-99m fanolesomab or technetium 99mtc fanolesomab

**UNSPSC Code**: 51442705
**Class**: [Technetium-based radiopharmaceuticals, imaging agents, media, and tracers](Technetium-based radiopharmaceuticals, imaging agents, media, and tracers.mdx)
**Family**: [Radiopharmaceuticals and contrast media](../Radiopharmaceuticals and contrast media.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a radioconjugate, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AMF7KOE318, more generally known as Technetium Tc 99m fanolesomab. The European Medicines Agency schedules Technetium Tc 99m fanolesomab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27898. The term Technetium Tc-99m fanolesomab is an International Non-Proprietary Name or INN. Most nations schedule Technetium Tc-99m fanolesomab or technetium 99mtc fanolesomab under HS 28444030.

